Market Research

Psychedelic Invest is your source for the latest business and investing news about the burgeoning psychedelics industry.

What’s The Real Value of ATAI Life Sciences?

Oct 30 • 7 min read

It’s no secret amongst psychedelic investors that ATAI Life Sciences has built up an impressive portfolio of companies. Backed by household names such as Peter Thiel, Mike Novogratz, and Steve Jurvetson, investors have been scrambling to be a part of the nearly $200 million raised to date. When and where the company will list is…

ATAI Life Sciences Has Massively Oversubscribed Series C

Oct 28 • 2 min read

Investors in the psychedelics industry have been scrambling the past couple of weeks to gain access to ATAI Life Sciences’ most recent funding round. This new round, which comes after having raised more than $100 million in past funding, is set to be the last opportunity for investors to participate before the company’s IPO. Labeled…

Kevin O’Leary: ‘Psychedelics Are My Highest Return This Year’

Oct 23 • 2 min read

“Out of all the sectors I’ve invested in, in this last year, that’s my highest return,” said Kevin O’Leary in a recent interview about his investments in two psychedelics companies that have gone public this year. O’Leary was speaking with Jon Najarian of football and CNBC fame on the Compound Interest podcast. The first psychedelics…

MindMed CEO, JR Rahn, Pledges Stock For Loan (Not Sale)

Oct 20 • 2 min read

There has been a lot of speculation circulating today after it appeared that the Founder and CEO of Mind Medicine (MMED), JR Rahn, sold half of his shares in the company. A sale by an insider, let alone a founder, of an early stage company is never a good sign as it implies that the…

The Right and Wrong Way To Invest in Psychedelics

Oct 20 • 5 min read

The usage of psychedelic drugs as a therapeutic tool will have an enormous payoff for patients who are seeking new ways to cope with mental health issues. But the advancement of psychedelics is also going to have massive payoffs for early investors in companies that provide these therapies. We are already starting to see a…

Pages: 1234567891011121314151617181920212223242526272829303132333435363738394041424344454647484950515253